U.S. Energy Services Stock News

Without a specific catalyst driving headlines, STERIS (STE) still attracts attention from investors reviewing its recent share performance and financial profile, particularly given its infection prevention focus across healthcare, life sciences, and sterilization services. See our latest analysis for STERIS. Recent share price returns for STERIS have been mixed, with the stock up 1.63% over the last day but down 14.39% year to date. The 1 year total shareholder return declined 6.13%,...

Honolulu Cookie Company recently announced that it is expanding its partnership with Square, now running Square’s retail platform, loyalty tools, and integrated inventory systems across 14 locations in Oahu, Maui, Las Vegas, and Guam, supporting a new flagship store concept opened in July 2026. This expansion shows how Square’s end-to-end ecosystem, from customer data and loyalty to inventory integrations and handheld devices, can underpin multi-location retailers’ efforts to scale...

Honeywell International Inc. previously declared a quarterly dividend of US$0.70 per share, payable on September 4, 2026, to shareholders of record on August 14, 2026, while also reporting second-quarter 2026 revenue of US$9,719 million and net income of US$5.68 billion. The very large year-over-year jump in net income and earnings per share highlights how Honeywell’s recent financial performance has differed from the prior year’s results. With this sharp improvement in reported...

Euronet Worldwide (EEFT) has drawn fresh attention after its recent share price move, with the stock up about 13% over the past month and roughly 5% over the past 3 months. See our latest analysis for Euronet Worldwide. Set against a 1 year total shareholder return that declined 23.6%, Euronet Worldwide’s recent 30 day share price return of 12.6% and 7.0% year to date share price gain suggest improving momentum as investors reassess growth prospects and risks. If this kind of renewed interest...

Conagra Brands recently reported fourth-quarter and full-year results to May 31, 2026, posting sales of US$2,882.1 million for the quarter and a net loss of US$1,616.9 million, driven largely by very large goodwill and intangible asset impairment charges, and the board approved a reduced quarterly dividend of US$0.175 per share. The company also completed a US$499.07 million fixed-income offering of 5.400% senior unsecured notes due 2031, which, alongside the impairments and dividend cut,...

Why KeyCorp’s latest credit metrics matter for stock investors KeyCorp (KEY) recently reported second quarter net loan charge offs of $115 million compared with $102 million a year earlier, giving investors fresh information on credit costs and loan performance across the bank’s portfolio. See our latest analysis for KeyCorp. The recent uptick in net loan charge offs and the reaffirmed common and preferred dividends come at a time when KeyCorp’s share price is US$22.65. Short term momentum...

In July 2026, Northrop Grumman reported higher second-quarter and first-half revenues year over year, raised its full-year 2026 sales guidance to a range of US$43.75 billion to US$44.25 billion, and outlined expectations for mid- to high single-digit third-quarter sales growth. The company also advanced its long-term deterrence footprint by breaking ground on a sixth building at its Roy Innovation Center to support the Sentinel ICBM program and related aerospace missions, expanding campus...

Softer June inflation, firm expectations that the Federal Reserve will keep rates on hold for now, and a fresh spike in oil prices are pulling income focused investors in different directions. On one side, a steady rate backdrop can support demand for US dividend growth stocks with solid balance sheets and consistent payouts. On the other, stubborn energy costs keep the risk of future rate hikes alive. This article looks at 3 stocks from our US Dividend Growth Stocks screener that appear...

In July 2026, Telix Pharmaceuticals announced it had entered a collaboration with Regeneron Pharmaceuticals to co-develop and commercialize next-generation radiopharmaceutical cancer therapies, with Telix receiving an initial non-refundable US$40 million payment on signing. Soon after, Regeneron was hit with a securities class action lawsuit alleging misleading disclosures about a Phase III Fianlimab-Libtayo trial, highlighting legal and credibility questions around its oncology pipeline...

Recently, Callaway Golf drew attention after analysts gave it a top Zacks Rank, reflecting a stronger earnings outlook and momentum versus Consumer Discretionary peers. The debate now centers on whether discount-driven traffic can support healthier long-term margins, raising fresh questions about the durability of its improving fundamentals. With this in mind, we'll explore how the upgraded earnings outlook, despite margin concerns, reshapes Callaway Golf's broader investment...

Packaging Corporation of America recently reported past second-quarter 2026 results, with sales rising to US$2,489.9 million while net income eased to US$192.1 million, leading to lower earnings per share than a year earlier. Alongside record corrugated shipments and early benefits from the Greif containerboard acquisition, the company also announced a containerboard price increase and a sharply higher dividend, underscoring management’s confidence in its operating momentum. Now we’ll...

Bank of America recently raised its regular quarterly common stock dividend to US$0.32 per share, a US$0.04 increase, and reported second-quarter 2026 net income of US$9,074 million on net interest income of US$15,997 million, both higher than a year earlier. This higher shareholder payout, alongside improved credit costs with net charge-offs easing to US$1,412 million, underscores how the bank is balancing capital returns with loan portfolio risk management. Next, we’ll explore how this...

Banner (BANR) is back on investors’ radar after its second quarter 2026 earnings report and dividend affirmation. The update offers fresh data on profitability, shareholder payouts and how the regional bank is positioned today. See our latest analysis for Banner. Banner’s 12.52% year to date share price return and 11.55% total shareholder return over the past year point to steady momentum. The 64.32% three year total shareholder return highlights how longer term holders have been rewarded as...

What the latest ManpowerGroup earnings mean for investors ManpowerGroup (MAN) is back in focus after the company moved from a net loss a year ago to net income in the second quarter of 2026, while also issuing fresh third quarter earnings guidance. The company reported second quarter net income of US$53.5 million and outlined an expected diluted earnings per share range of US$0.96 to US$1.06 for the upcoming quarter, including an estimated 2 cent currency headwind. See our latest analysis for...

The U.S. Food and Drug Administration has granted Philip Morris International (PM) permission to market its ZYN nicotine pouches as modified risk tobacco products, marking the first such designation for smoke free pouches in the U.S. See our latest analysis for Philip Morris International. For investors, this FDA milestone comes during a strong period for Philip Morris International, with a 19.95% 90 day share price return and a 143.58% five year total shareholder return. This suggests that...

Easterly Government Properties (DEA) is drawing investor interest after recent share price moves, with the stock last closing at $25.33. This price puts the government-focused REIT’s market value at about $1.30b. See our latest analysis for Easterly Government Properties. Over the past year, Easterly Government Properties has combined an 18.86% year-to-date share price return with a 20.11% total shareholder return. The 3-year and 5-year total shareholder returns are 10.78% and 35.31% lower,...

Regions Financial earnings and dividend move into focus Regions Financial (RF) is back on investors’ radar after reporting second quarter 2026 results that included modestly higher net interest income and net income, paired with a 13% increase in its quarterly common dividend. See our latest analysis for Regions Financial. Regions Financial’s recent earnings, dividend uplift and completed share buyback have arrived alongside an 11.97% year to date share price return and a 21.48% total...

Guidewire Software, Inc. announced that Alexander Vollert joined its Board of Directors on August 1, 2026, bringing extensive senior insurance and technology leadership experience from AXA and Allianz. In parallel, Germania Mutual Insurance Company adopted Guidewire’s ProNavigator AI assistant for underwriting and claims, highlighting how insurers are embedding Guidewire’s AI directly into everyday workflows on its core platform. We’ll now examine how Germania Mutual’s rollout of...

MapLight Therapeutics (MPLT) has drawn investor attention recently as its clinical-stage central nervous system pipeline, including candidates for schizophrenia, Alzheimer’s disease psychosis and Parkinson’s disease, trades around $36.56 with a market value near $1.66 billion. See our latest analysis for MapLight Therapeutics. For context, MapLight Therapeutics’ share price return has been strong over 2024, with a year to date gain of 118.01% and a 90 day share price return of 19.32%...

How Louisiana-Pacific Stock Has Been Trading Recently Louisiana-Pacific (LPX) has seen mixed share performance recently, with the stock up 3.2% over the past day and slightly higher over the past week, but down over the past month and over the past three months. See our latest analysis for Louisiana-Pacific. At a share price of $74.48, Louisiana-Pacific has seen a 1-year total shareholder return that is down 15.9%, while the 5-year total shareholder return of 43.72% points to a much stronger...

Axsome Therapeutics recently reported that the FDA accepted for filing its New Drug Application for AXS-12 (reboxetine) to treat cataplexy in narcolepsy, with a Prescription Drug User Fee Act target action date set for May 1, 2027, and no advisory committee meeting currently planned. This regulatory milestone advances Axsome’s late-stage pipeline in a serious orphan neurological condition, potentially reinforcing the company’s focus on differentiated central nervous system therapies. We’ll...

In July 2026, Zevra Therapeutics reported that the European Medicines Agency’s Committee for Medicinal Products for Human Use issued a negative opinion on the Marketing Authorization Application for arimoclomol in Niemann-Pick disease type C, prompting the company to seek a formal re-examination while maintaining patient access through its global Expanded Access Program. The updated international Consensus Clinical Management Guidelines for Niemann-Pick disease type C highlight arimoclomol...

W.W. Grainger stock has delivered a very strong 227.4% return over the past five years, yet current checks suggest investors are now paying a premium, with both the Discounted Cash Flow (DCF) intrinsic value estimate and market multiples pointing to an overvalued share price. A 227.4% five year return highlights how strongly W.W. Grainger has rewarded long term shareholders and raises the bar for what future performance needs to justify today’s price. Expectations for continued profit growth...

MARA Holdings (MARA) is back in focus after recent moves to repurpose some Bitcoin mining sites for high performance computing, continued Bitcoin sales to reduce debt, and rising attention ahead of its upcoming earnings report. See our latest analysis for MARA Holdings. MARA Holdings’ recent repurposing of mining sites toward high performance computing, continued Bitcoin sales to reduce debt, and attention around the upcoming earnings report have come alongside choppy trading, with a 7 day...